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Abstract. Click chemistry refers to a group of reactions that are fast, simple to use, easy to purify,
versatile, regiospecific, and give high product yields. While there are a number of reactions that fulfill the
criteria, the Huisgen 1,3-dipolar cycloaddition of azides and terminal alkynes has emerged as the
frontrunner. It has found applications in a wide variety of research areas, including materials sciences,
polymer chemistry, and pharmaceutical sciences. In this manuscript, important aspects of the Huisgen
cycloaddition will be reviewed, along with some of its many pharmaceutical applications. Bioconjugation,
nanoparticle surface modification, and pharmaceutical-related polymer chemistry will all be covered.
Limitations of the reaction will also be discussed.
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INTRODUCTION
In the field of pharmaceutical science, researchers are
constantly seeking for new molecules and constructs that
exhibit specific properties. While one could easily come up
with a structure design that would fit the needs, the real
struggle lies in its synthesis and purification. If only molecular
synthesis were as simple as building a LEGO® castle or
assembling an IKEA® desk. If only readily available
structure units could be easily linked together to form
numerous molecules of desire in just a few crisp steps. While
it still remains a far-reaching dream, the new concept of click
chemistry seems to offer a glimpse of hope.
Since being first introduced by Dr. Barry Sharpless’
group in 1999 at the 217th American Chemical Society annual
meeting, click chemistry has become a very popular topic, as
evidenced by a nearly exponential growth in the amount of
related publications. A literature search via SciFinder Schol-
ar®, performed on December 31st of 2007, revealed a total of
788 publications containing the keywords “click chemistry” or
“click reaction”, which included journal articles, reviews,
preprints, abstracts, patents, and dissertations. As shown in
Fig. 1, publications in this area have quickly increased over
the past 4 years.
In his landmark review in 2001, Dr. Sharpless defined
click chemistry as a group of reactions that “…must be
modular, wide in scope, give very high yields, generate only
inoffensive byproducts that can be removed by nonchromato-
graphic methods, and be stereospecific (but not necessarily
enantioselective). The required process characteristics include
simple reaction conditions (ideally, the process should be
insensitive to oxygen and water), readily available starting
materials and reagents, the use of no solvent or a solvent that
is benign (such as water) or easily removed, and simple
product isolation. Purification, if required, must be by non-
chromatographic methods, such as crystallization or distilla-
tion, and the product must be stable under physiological
conditions” (1). The identification of this group of reactions
was a direct result of Mother Nature’s strategy of achieving
astonishing biological diversity from a very limited number of
monomers (i.e. proteins from amino acids, nucleic acids from
nucleotides, etc.). Puzzled by the slowness and inefficiency of
the conventional drug discovery process, Dr. Sharpless
proposed a new tactic, one in where large combinatorial
libraries could be easily prepared by linking available
building blocks via click reactions. The rule of thumb for this
approach was that “…all searches must be restricted to
molecules that are easy to make” (1).
Although this novel philosophy for drug discovery is very
appealing, the medicinal chemists in this field seem to be
hesitant. As shown in Fig. 2, among all the publications
identified through SciFinder Scholar®, only 14% are drug
discovery related. Interestingly, applications of click reactions
in polymer sciences are warmly welcomed and considered as
an immediate success. Biomedical applications of click
chemistry, especially in pharmaceutical sciences, are also
emerging as a field of great interest. One reason is in many
areas of research, such as drug delivery and nanomedicine,
linker chemistry plays a pivotal role. Biological therapeutics
needs to be tagged with probes for the convenience of
detection and evaluation. Nanoscale delivery vehicles need
to be assembled to provide drug transportation in vivo.
Targeting moieties and drug(s) need to be attached or loaded
onto delivery systems. These are very tedious tasks as there
are many constraints on performing successful linker chem-
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istry. For instance, they are typically performed in water.
Furthermore, the reaction conditions are preferred to be mild
so that biologicals and other fragile structures present will not
loss their functions. Protections and deprotections also need
to be considered to avoid unwanted side reactions. Click
chemistry, through its unique features, easily satisfies all of
these constraints. It has repeatedly shown to serve the needs
of the pharmaceutical community exceedingly well, despite
the fact that it was intended to serve an entirely different
purpose. In this review, important aspects of click chemistry
will be discussed, along with its emerging applications in drug
delivery and nanomedicine. We will also provide some of our
concerns and vision for its future development in pharma-
ceutical sciences. Several reviews on click chemistry have
already been published (1–3). The readers may find them
helpful in understanding other aspects of click chemistry or in
obtaining more background information.
CLASSIFICATION OF CLICK REACTIONS
As already implicated, click chemistry encompasses a
group of powerful linking reactions that are simple to
perform, have high yields, require no or minimal purification,
and are versatile in joining diverse structures without the
prerequisite of protection steps. To date, four major classi-
fications of click reactions have been identified (Fig. 3).
& Cycloadditions—these primarily refer to 1,3-dipolar cyclo-
additions, but also include hetero-Diels-Alder cycloadditions
(2).
& Nucleophilic ring-openings—these refer to the openings of
strained heterocyclic electrophiles, such as aziridines, epox-
ides, cyclic sulfates, aziridinium ions, episulfonium ions, etc.
(2).
& Carbonyl chemistry of the non-aldol type—examples






















Fig. 1. Number of publications containing the key words “click
chemistry” or “click reaction” from 1999–2007. The literature search
was performed via SciFinder Scholar® on Dec. 31, 2007 and included
journal articles, abstracts, preprints, dissertations, patents, and

























Fig. 2. Major classifications of the applications of click chemistry.
Analysis was performed based on a literature search via SciFinder
Scholar® on Dec. 31, 2007. The search included journal articles,
abstracts, preprints, dissertations, patents, and reviews. The field of
drug discovery was considered separate from pharmaceutical and the
category “other” contains miscellaneous applications that cannot be
grouped into the other three categories, such as applications in
materials sciences, certain reviews, and novel methods for improved
catalysts. Many applications are subjective in that they can fall into
more than one category (i.e. the synthesis of certain block copolymers
could be considered both pharmaceutical and polymer-related). In
these cases, the applications were categorized as pharmaceutical if
and only if their corresponding abstracts specifically mentioned that
the involved compound(s) could play a role in a pharmaceutical
setting. It is intended for this chart to represent a general overview






































Byproduct+ X = O, NR, +SR, +NR2R2








Fig. 3. Major classifications of click chemistry reactions, along with
corresponding examples. Nu Nucleophile; EWG electron withdraw-
ing group.
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ethers, amides, aromatic heterocycles, etc. (1). Carbonyl
reactions of the aldol type generally have low thermodynamic
driving forces, hence they have longer reaction times and give
side products, and therefore cannot be considered click
reactions (1).
& Additions to carbon-carbon multiple bonds—examples
include epoxidations, aziridinations, dihydroxylations, sul-
fenyl halide additions, nitrosyl halide additions, and certain
Michael additions (1,2).
Among the four major classifications, cycloadditions,
particularly the CuI-catalyzed Huisgen 1,3-dipolar
cycloaddition (HDC) of azides and terminal alkynes to form
1,2,3-triazoles (4), are the most widely used. Based on the
literature search mentioned earlier, nearly 100% of the
publications referred to this click reaction, which has found
applications across many diverse research areas. In the
following sections, the potential of this click reaction and its
pharmaceutical applications will be reviewed.
CuI-CATALYZED HUISGEN 1,3-DIPOLAR
CYCLOADDITION OF AZIDES AND TERMINAL
ALKYNES
The CuI-catalyzed Huisgen 1,3-dipolar cycloaddition of
azides and terminal alkynes to form 1,2,3-triazoles is the
model example of a click reaction (Fig. 3). It fulfills all of the
criteria of click chemistry perfectly, no matter how subjective
they may be, and is therefore extremely reliable and easy to
use. This reaction exclusively forms 1,4-substituted products,
making it regiospecific. It typically does not require
temperature elevation but can be performed over a wide
range of temperatures (0–160°C), in a variety of solvents
(including water), and over a wide range of pH values (5
through 12). It proceeds as much as 107 times faster than the
uncatalyzed version, and purification essentially consists of
product filtration (3,5–7). Furthermore, it is unaffected by
steric factors. “Variously substituted primary, secondary,
tertiary, and aromatic azides readily participate in this
transformation. Tolerance for variations in the acetylene
component is also excellent” (6). All of these characteristics
make this cycloaddition particularly popular among the other
click reactions described above.
Two additional reasons for the popularity of this
cycloaddition are azides and terminal alkynes are fairly easy
to install and they are extremely stable at standard conditions
(2,8). They both can tolerate oxygen, water, common organic
synthesis conditions, biological molecules, a large range of
solvents and pH’s, and the reaction conditions of living
systems (reducing environment, hydrolysis, etc.) (2,3,9). Even
though the decomposition of aliphatic azides is thermody-
namically favored, a kinetic barrier exists that allows them to
be stable in the aforementioned conditions (3). They will
essentially remain “invisible” in solution until a dipolarophile,
such as an alkyne, comes into contact (3).
Mechanism of HDC Reaction
In general, cycloadditions proceed through a concerted
mechanism. However, experimental kinetic data (10) and
molecular modeling (7) performed on the HDC reaction
seem to favor a stepwise reaction pathway (3,5). It has been
calculated that the activation barrier for a catalyzed concerted
HDC reaction is actually greater than that for an uncatalyzed
concerted reaction (27.8 kcal/mol vs. 26 kcal/mol in one
particular reaction using density functional theory calcula-
tions) (7). Furthermore, a stepwise-catalyzed HDC reaction
has an activation barrier 11 kcal/mol lower than a concerted
catalyzed reaction (3).
Based on experimental evidence (5,6) and the fact that
CuI can readily insert itself into terminal alkynes
[Sonogashira coupling (11)], it is envisioned that the first
step of the reaction involves π complexation of a CuI dimer to
the alkyne (1 in Fig. 4). Thereafter, deprotonation of the
terminal hydrogen occurs to form a Cu-acetylide (5). There
are actually several different kinds of Cu-acetylide complexes
that can form, depending on the reaction conditions utilized;
2 represents just one possibility (7). The π complexation of
CuI lowers the pKa of the terminal alkyne by as much as 9.8
pH units, allowing deprotonation to occur in an aqueous
solvent without the addition of a base (3). If a non-basic
solvent such as acetonitrile was to be used, then a base, such
as 2,6-lutidine or N,N′-diisopropylethylamine (DIPEA),
would have to be added (12).
In the following step, N(1) displaces one of the ligands
from the second Cu in the Cu-acetylide complex to form 3. In
turn, this “activates” the azide for nucleophilic attack C(5).
Due to proximity and electronic factors, N(3) can now easily
attack C(4) of the alkyne, leading to a metallocycle (not
shown for simplicity). The metallocycle then contracts when
the lone pair of electrons of N(1) attacks C(5) to form the
respective triazole 4. Once 4 forms, the attached Cu dimer
immediately complexes to a second terminal alkyne. Howev-









































Fig. 4. Proposed mechanism for the HDC reaction. Ligands are
represented by “L” and symbolize a wide variety of possible
compounds, depending on the catalyst used. As an example, if CuBr
was used as the catalyst then the ligand would be bromide. Figure
adapted from reference 3 with permission from Wiley-VCH.
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the unfavorable structure of the complex, and it dissociates
upon protonation to reform 4. One final protonation releases
the CuI catalyst from the 1,2,3-triazole product 5, to undergo
a second catalytic cycle with different substrates (3). Both of
these protonations are most likely the result of interactions
with protonated external base and/or solvent, but further
studies are needed to conclusively confirm (3).
Catalysts
There are a number of methods to generate the active
catalyst for the HDC reaction. One of the most common
techniques is to reduce CuII salts, such as CuSO4·5H2O, in
situ to form CuI salts. Sodium ascorbate is typically used as
the reducing agent in a 3- to 10-fold excess (3), but other
reducing agents, including hydrazine (13) and tris(2-
carboxyethyl)phosphine (TCEP) (9), have been used with
reasonable success. The advantages of this strategy are it is
cheap, it can be performed in water, and it does not require
deoxygenated atmosphere (3,14). Not only does an aqueous
solvent remove the need for a base, as previously explained,
but it also eliminates the need for protecting groups (O–H and
N–H functional groups essentially remain “invisible” in aqueous
solutions) and it is environmentally safe (1). The main
disadvantage is the reducing agent might reduce CuII down to
Cu0. This can generally be prevented, though, by using a proper
ratio of reducing agent to catalyst and/or adding a copper-
stabilizing agent, such as tris-(hydroxypropyltriazolylmethyl)
amine (THPTA) (3).
A second way to create the catalyst is to directly add CuI
salts. Many such compounds have been utilized over the past
few years, including CuBr, CuI, CuOTf·C6H6 (OTf=
trifluoromethanesulfonate), [Cu(NCCH3)4][PF6], etc. (6).
This method does not require a reducing agent, but it has to
be done in a deoxygenated environment and in an organic
solvent (or a mixed solvent), meaning that protection groups
will probably be needed along with a base (14). It has been
shown that using excess amounts of both the bases 2,6-
lutidine and DIPEA produce the best results, causing the
least amount of side products (6,12). Still, CuI salts are not as
reliable as the CuII procedure (6).
Oxidizing copper metal with an amine salt is another way
to generate the catalyst (7,14). There are a considerable
number of disadvantages with this strategy. Longer reaction
times are needed, as well as larger amounts of copper, it is
more expensive, and requires a slightly acidic environment to
dissolve the metal, which could be damaging to any acidic-
sensitive functional groups present in the reactants (3). For
more information on this method or any of the others
mentioned thus far, refer to reference 3 for an exquisite review.
Recently, CuI-modified zeolites were reported as
catalysts for the HDC reaction (15). “Zeolites” refers to a
family of aluminosilicate minerals, occurring both naturally
and synthetically, that are highly porous and therefore have
large surface areas (16–18). They are particularly desired as
catalysts because of their “…high concentration of active acid
sites, their high thermal/hydrothermal stability, and high size
selectivity” (18). In one particular HDC reaction, the zeolite
USY, modified with CuI, exhibited far better results than
CuCl. Its product yield was thirteen percent higher and its
reaction time was roughly three times as short (15). Pending
more research, this approach could prove to be very valuable.
Another research group has attempted to find a replace-
ment for copper as the catalyst. Knowing that other transition
metals can insert into alkynes (19,20), Golas et al. reacted
propargyl ether with azide-terminated polystyrene to make
polymers using three different catalyst: NiCl2, PtCl2, and PdCl2
(13). Although none of them displayed catalytic activity as high
or as fast as CuBr, they all produced polymerization products.
PtCl2 produced polymers with the highest molecular weight,
followed by PdCl2, followed by NiCl2.
In 2005, pentamethyl cyclopentadienyl ruthenium (II)
complexes (Cp*Ru), such as Cp*RuCl(PPh3)2, were discov-
ered as novel catalysts for click chemistry. Contrary to all
previously mentioned catalysts, Cp*Ru complexes afford only
1,5-substituted 1,2,3-triazoles (21). Furthermore, they can
work on both terminal and internal alkynes alike (22). An
example of such a reaction is shown in Fig. 5. Due to their
recent discovery, though, limited information is available
detailing the role of ruthenium(II) complexes in click
chemistry, as evidenced by a search via SciFinder Scholar®.
Finally, studies have shown that catalysts are not always
required for the cycloaddition to proceed. By using electron
deficient alkynes, the reaction can proceed readily at ambient
conditions (23). However, electron deficient alkynes are very
reactive toward nucleophiles and can lead to side products
(24), which has kept these types of reactions estranged from
the field of click chemistry. Other studies have shown that the
cycloaddition can occur rapidly if the alkyne is first incorpo-
rated into an eight-member ring, forming a cyclooctyne (24–
26). Cyclooctynes are very unstable, due to a high degree of
ring strain (18 kcal/mol), which causes them to react readily
with azides (24). While this method leaves no side products
and requires no cytotoxic catalysts, it requires the prerequi-
site of connecting the alkyne of interest to an eight-member
ring. This can be a very challenging task and is much more
complicated than simply adding an acetylene functional
group, as in traditional click reactions. An additional concern
with the cyclooctyne method is it produces a racemic mixture
of regioisomers (Fig. 6) (24). This stipulation is typically
inconsequential to pharmaceutical applications, but it defies
the very definition of click chemistry, which requires click
reactions to be regiospecific.
APPLICATIONS OF CLICK CHEMISTRY
IN PHARMACEUTICAL SCIENCES
Since its debut in 1999, click chemistry has stimulated
enormous amount of interests in many different research
fields, being utilized in everything from microelectronics to









Fig. 5. Using a Cp*Ru catalyst in the click reaction exclusively forms
1,5-substituted 1,2,3-triazoles. These catalysts can also work on
internal alkynes (not shown), contrary to all other known catalysts.
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sections, an in-depth look will be taken at some of its
applications pertaining to the field of pharmaceutical scien-
ces. The area of drug discovery will be excluded since
multiple review papers on this subject already exist (2,27–29).
Polymer Therapeutics and Click Chemistry
“‘Polymer therapeutics’ is an umbrella term used to
describe polymeric drugs, polymer-drug conjugates, polymer-
protein conjugates, polymeric micelles to which drug is
covalently bound, and multi-component polyplexes that are
being developed as non-viral vectors. All subclasses use
specific water-soluble polymers, either as the bioactive itself
or as an inert functional part of a multifaceted construct for
improved drug, protein, or gene delivery” (30). While
polymer therapeutics have been used to treat numerous
diseases, they are particularly effective against those that
have an enhanced permeability and retention (EPR) effect
(31), such as rheumatoid arthritis (32) and solid tumors (33).
Non-viral gene therapy formulations based on synthetic
polymers have been extensively investigated and have shown
better safety profiles than viral gene vehicles, though their
gene transfection efficacy is relatively low (34). Conjugation
of biocompatible polymers, such as poly(ethylene glycol)
(PEG), to therapeutic proteins and peptides has proved to be
a very effective strategy in reducing immunogenicity and
increasing bioavailability (35,36). Clearly, biocompatible poly-
mers have played vital roles in modern pharmaceutical
sciences, especially in drug delivery and formulations. Never-
theless, simpler and more efficient polymer chemistry is
needed to meet the ever-increasing demand for highly diverse
pharmaceutical properties.
As explained in previous sections, click chemistry was
initially developed as a drug discovery tool. However, its most
successful applications thus far have been in the field of
polymer chemistry. As seen in Fig. 2, over one third of all
publications containing the keywords “click chemistry” or
“click reaction” are related to polymer synthesis and/or
modification. Generally, these publications can be classified
into five broad categories: block copolymer synthesis, linear
multifunctional copolymer synthesis, dendrimer synthesis,
polymer network synthesis, and polymer analogous modifica-
tion. In addition to significantly improving product yields,
most of these click chemistry applications drastically simpli-
fied the synthetic routes and purification procedures. There-
fore, it is the belief of the authors that this new “tool in the
box” may shift the paradigm of polymer synthesis and lead to
new strategies of polymer therapeutics development.
Synthesis of Block Copolymers with Click Reaction
Biocompatible amphiphilic block copolymers have many
pharmaceutical applications. They have been extensively
used in the formulation of various nanoparticulate structures,
such as micelles, nanospheres, nanocapsules, polymersomes,
etc. (37–39). Typically, block copolymers are synthesized via
two routes: (A) sequential addition of different monomers
into polymerizations containing living reaction centers
(40,41). Living ionic polymerizations, atom transfer free
radical polymerizations (ATRP), reversible addition fragmen-
tation chain transfer (RAFT) polymerizations, ring-opening
polymerizations (ROP), or their combination have all been
utilized to obtain well-defined block copolymers of different
components. (B) Linking different linear polymer chains via
their terminal functionalities. While the latter method allows
the combination of polymer blocks that may not be compat-
ible with the first, the lack of efficient linker chemistry has
made this route rarely used.
The emergence of click chemistry drastically changed the
scientific community’s views on block copolymer synthesis.
Because of its extremely high reaction efficiency and toler-
ance to a variety of functional groups, click chemistry has
become the hallmark of linker chemistry. It is one of the most
efficient ways to join two substances together and has thus
been used repeatedly to link well-defined homopolymers to
form block copolymers. Recently, Van Camp et al. reported a
synthetic strategy for diverse amphiphilic copolymer struc-
tures by combination of ATRP and the HDC reaction. Using
a modular approach, polymers with alkyne functionalities as
well as polymers with azide functionalities [e.g. poly(1-
ethoxyethyl acrylate) and poly(acrylic acid)], were first
synthesized via ATRP. They were then subsequently
“clicked” together to yield block copolymers (42). Similarly,
Opsteen et al. described the synthesis of polystyrene (PS),
poly(tert-butyl acrylate) (PtBA), poly(methyl acrylate)
(PMA) block copolymers using click chemistry (43). Using
an initiator containing a triisopropylsilyl (TIPS) protected
acetylene, the three homopolymer blocks were obtained via
ATRP and the terminal bromides were then converted to
azides. Following TIPS deprotection, the heterotelechelic
homopolymers were joined together via HDC reactions.
When RAFT polymerization was employed to obtain the
homopolymer blocks, however, specially functionalized chain
transfer agents had to be synthesized to allow the introduc-
tion of terminal azides or acetylenes (44,45). Additionally,
this modular strategy of clicking different homopolymer
blocks together has also been exploited by numerous other
research teams (46–49). Among these works, one report
focused on the synthesis of well-defined block copolymers
composed of a rigid polypeptide sequence poly(g-benzyl-L-
glutamate), or PBLG, and a poly[2-(dimethylamino)ethyl
methacrylate] (PDMAEMA) block (46). The azide and
terminal alkyne functionalities were introduced into the α-
positions of both the PBLG and PDMAEMA precursors by
using appropriate α-ω-functionalized initiators. The PBLG
block was obtained by ring-opening polymerization of γ-
benzyl-L-glutamate N-carboxyanhydride (NCA), and the
PDMAEMA blocks from ATRP of 2-(dimethylamino)ethyl
methacrylate. Although this approach of incorporating a











Fig. 6. Huisgen 1,3-dipolar cycloadditions of azides and alkynes
without CuI catalyst. If an alkyne is first incorporated into an eight-
member ring then a 1,3-dipolar cycloaddition of azides and alkynes
can proceed rapidly without the aid of a catalyst. However, a racemic
mixture of regioisomers is obtained.
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need of column chromatography for purification violates
Sharpless’ definition of a click reaction. Hence, one could
make the argument that this copolymer application does not
actually utilize click chemistry.
Clearly, click chemistry has revitalized the second
strategy of block copolymer synthesis. Many monomers that
cannot be used to produce block copolymers via living
polymerizations (due to extremely disparate reactivities or
solubility differences) can now be easily incorporated through
the second strategy. Quite literally, with click chemistry, any
two homopolymer blocks can be joined together to form
block copolymers. This opens the door for combinatorial
block copolymer synthesis, allowing diverse copolymers with
very unique properties to be synthesized quickly and easily,
which could potentially lead to great strides in the field of
pharmaceutical sciences.
Click Chemistry and Polymeric Micelles
One of the main pharmaceutical applications of amphi-
philic block copolymers is the construction of polymeric
micelles as delivery vehicles for therapeutic, imaging, or
diagnostic agents (50–52). Although polymeric micelles are
simple and effective delivery systems that have been evalu-
ated in clinical treatments for various cancers, they still face
several challenges such as stability and control of drug
release. To improve these problem areas, many different
methodologies have been explored (53,54). One of the most
promising methods was developed by Wooley’s group at
Washington University.
As a novel method for stabilizing polymeric micelles, the
group reported the synthesis of well-defined core crosslinked
polymeric micelles, utilizing multi-functional dendritic cross-
linkers (55). Amphiphilic diblock copolymers of poly(acrylic
acid)-b-poly(styrene) (PAA-b-PS) were first functionalized
with terminal alkynes throughout the hydrophobic polysty-
rene block segment to form micelles that were click-readied
for crosslinking. Azide functionalized 1st generation den-
drimers were then “clicked” with the alkynyl groups of the
micelles to form core crosslinked micelles. It was estimated,
on average, that 3.4 polymer chains were conjugated to each
dendrimer. The remaining click-readied functionalities (both
terminal alkynes and azides) could be used as handles for
further chemical modifications, such as conjugating dyes.
In addition to crosslinking micelles, the same group was
able to introduce click-readied functionalities selectively
throughout either the core or shell of micelles (56). After
obtaining a poly(acrylic acid)-b-polystyrene copolymer mi-
celle, it was modified so that poly(acrylic acid) within the
micelle shell displayed either azido or alkynyl functional
groups via amidation chemistry. Using amidation chemistry
once more, the unreacted acrylic acids were linked together
via a diamine linker, crosslinking the shell of the micelle in an
intramicellar fashion. Following similar chemistry, a shell-
crosslinked micelle containing click-readied functional groups
in the polystyrene core was also prepared. The availability
and reactivity of the functional groups in both of these
crosslinked micelles towards click chemistry was demonstrat-
ed by reactions with complementary click-functionalized
fluorescent dyes. Studies by analytical ultracentrifugation
sedimentation confirmed the covalent attachment of the
fluorescent tags in the core or shell regions of the crosslinked
micelles.
While the strategies used by this research team are very
appealing, they are still in their early stages of development
for pharmaceutical applications. The polymers used in their
studies are not biocompatible. Therefore, it would be of
immense importance to see if the same chemistry is applica-
ble to biocompatible block copolymers such as polyester/
polyethylene glycol block copolymer systems, which are often
used in drug delivery.
Click Chemistry and Linear Multifunctional Polymeric
Delivery Systems
The most commonly used biocompatible water-soluble
polymers for drug delivery include N-(2-hydroxypropyl)
methacrylamide (HPMA) copolymers, polyglutamate, and
PEG. Among them, HPMA copolymer is the most extensive-
ly studied drug carrier, with more than half of all polymeric
drug conjugates in clinical evaluations based on this polymer
(57,58). Polyglutamate-drug conjugates, on the other hand,
are the most advanced in clinical evaluation with polygluta-
mate-paclitaxel in phase III clinical trial (59,60). As for PEG,
its main clinical applications are PEGylations of protein
therapeutics to alter their pharmacokinetics and render them
nonimmunogeneic (61). It has also been used as a carrier for
chemotherapeutic agents (62).
While the field of water-soluble polymeric drug con-
jugates has gradually matured over the past few decades,
challenges still remain in many aspects of its development: (1)
compared to the construction of other drug delivery systems
(e.g. liposome, micelles and nanoparticles), the synthesis of
polymer-drug conjugate is relatively complex. For carriers
based on vinyl polymers such as HPMA copolymer, the
introduction of a new drug to the conjugate often involves
multi-step synthesis of a new drug-containing vinyl monomer
and its subsequent copolymerization with HPMA and other
co-monomers. (2) Another issue is the nondegradable nature
of vinyl polymers and PEG. While a polymer carrier with
high molecular weight (MW) would render a long half-life for
the conjugated drug in circulation, the MW must be set lower
than the threshold of the renal glomerular filtration to avoid
chronic accumulation of the polymer carrier in vivo and its
potential negative impact. (3) Due to the recent advancement
of living free radical polymerizations, the MW and polydis-
persity index (PDI) of vinyl polymer–drug conjugates may be
properly controlled. Nevertheless, the distribution of func-
tionality along the polymer backbone still cannot be con-
trolled. (4) Different from vinyl polymers and polyglutamate,
PEG has limited sites for functionalization. Only the two
chain termini can be used for drug conjugation, which
significantly lowers the drug loading capacity of PEG as a
carrier.
As one of the potential solutions to these challenges, a
linear multifunctional PEG design has been proposed as a
polymeric drug carrier (63). The concept is to join short
telechelic PEGs with tri-functional linkers. While two func-
tionalities will be used to link the PEGs, the third one will be
used for drug conjugation. Different from traditional PEG
designs, it has multiple functionalities pendent to the polymer
backbone. Short peptide sequences can also be introduced
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into the polymer main chain to allow biodegradation of the
polymer carrier into short PEG segments. The length of the
short PEG predetermines the distance between adjacent
functionalities. With this method vinyl monomer synthesis is
no longer necessary. While several approaches have been
made to synthesize the linear multifunctional PEG construct
(63–66), further improvements are desperately needed. In
particular, the chemistry that joins the short PEG segments
should be much more efficient, and tolerant of pendent
functionality conjugation.
Recently, Liu et al. (67) used click chemistry to synthe-
size a linear multifunctional PEG as a novel drug delivery
system. PEG oligomer diol was first activated with phosgene
and capped with propargyl amine so that it was acetylene
terminated. This was to serve as the polymer building block.
A diazide monomer, 2,2-bis(azidomethyl)propane-1,3-diol,
and various functional derivatives were synthesized as the
functionality building blocks. All of these building blocks
were dissolved in water and copolymerized in a step-growth
fashion via the HDC reaction. Due to the self-catalyzing
feature that has been observed in click reactions using 2,2-bis
(azidomethyl)propane-1,3-diol (5), this click copolymeriza-
tion was shown to be highly efficient. The strategy was used
to synthesize a prototype bone-targeting PEG conjugate that
used alendronate (a bisphosphonate) as the targeting moiety.
The content of alendronate could be easily adjusted since the
copolymerization was performed in water, a good solvent for
bisphosphonates. Compared to traditional synthetic polymer-
ic delivery systems, the advantages of this approach are that
the entire synthetic procedure is modular, simple, free from
vinyl chemistry, and produces high yields; no special reaction
condition(s) or protection steps are needed; oligopeptide
sequences can be easily inserted between PEG and the
acetylene functionality to allow biodegradability of the
delivery system. Furthermore, by adding some monoacety-
lene-functionalized PEG to the system, Liu et al. have been
able to control the average molecular weight. More work
needs to be done, however, to improve the wide polydisper-
sity of the copolymer.
Other Polymer-Related Applications of Click Chemistry
Due to their concentrated surface functionality and
narrow polydispersity, dendrimers have been actively inves-
tigated as potential drug delivery carriers (68,69). They are
typically synthesized via two strategies: by the divergent
approach or by the convergent approach. Without elabora-
tion, both approaches are often complicated, involving
multiple reaction steps, and both require extensive purifica-
tion. Click chemistry can greatly simplify the synthesis of
dendrimers, making them more applicable and affordable.
As an example of a dendrimer used for drug delivery,
Gopin et al. (70) reported the synthesis and evaluation of
a single-triggered disassemble dendrimer as a potential
platform for a multi-prodrug. “These unique structural
dendrimers can release all of their tail units through a self-
immolative chain fragmentation that is initiated by a single
cleavage at the dendrimer’s core” (70). To allow enzymatic
activation of the second-generation of self-immolative den-
drimers, azide-monoterminated PEG was conjugated to the
dendritic platform via click chemistry, which prevented
aggregate formation of the hydrophobic drugs.
Polymer networks such as hydrogels are also often used
in drug delivery (71,72). A few attempts have been made to
use click chemistry to synthesize polymer networks with high
efficiency and reduced defects (73–75). The problem with this
approach, however, is the difficulty of removing copper
catalyst from the network.
As discussed above, polymer analogous reactions are not
very efficient due to the steric hindrance caused by the
polymer backbone. There are often unreacted pendent
functional groups leftover. Because of its high reaction yield
and mild reaction conditions, people have tried to introduce
azides or acetylenes as novel pendent functionalities to the
polymer backbone so that it can be used for further click
modifications (76,77). One concern, however, is that this
strategy will make sense only when the click functionalities
are introduced by copolymerization, not polymer analogous
reaction.
Click Chemistry and Nanoparticular Delivery Systems
Nanoparticular delivery systems are the carriers ranging
in size from 10 to 1000 nm. Over the past few decades,
delivery systems such as quantum dots, magnetic nano-
particles, gold nanoparticles, micelles, and liposomes have
all been extensively investigated for imaging and drug/gene
delivery applications (78,79). Due to the small size, they are
able to penetrate through fenestrated vasculature, allowing
efficient drug accumulation at target sites. Moreover, drug
targeting by nanoparticular delivery systems offers several
important advantages: they reduce drug dose, minimize side-
effects, protect drugs against degradation, and enhance drug
stability (80).
Surface modifications of these carriers can have signifi-
cant impacts on their physical-chemical properties and
therapeutic efficacy. They can alter nanoparticle zeta poten-
tials, hydrophobicities, and targeting capabilities. These
modifications can be performed using a variety of techniques,
including physical adsorption, electrostatic binding, specific
recognition, and covalent coupling, each of which has its own
advantages and disadvantages (79). In this part of the review,
the application of click chemistry towards the modification of
nanoparticular carrier surfaces will be examined.
Gold and Magnetic Nanoparticles
The use of gold nanoparticles in pharmaceutical research
has become a well-established practice, as evidenced by the
ever-growing plethora of scientific literature. Due to their
unique physical properties (81), they have been used to label
antibodies (82), target polynucleotides (83), in cancer cell
diagnostics (84), in drug delivery systems (85), etc. Many of
these methods, however, rely on the non-covalent attach-
ments of biological molecules, which have important draw-
backs (86). For instance, non-covalent interactions are much
weaker than covalent bonds, meaning that it is much easier to
break apart the nanoparticle-biological molecule conjugate.
For long-term conjugation, covalent bonds must be used. One
study performed by Brennan et al. showed that bioconjuga-
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tions to gold nanoparticles via covalent bonds could occur
easily and rapidly with click chemistry (86).
Gold nanoparticles were first prepared and functional-
ized with azide groups at the surface. A lipase enzyme (a
30 kDa globular recombinant protein) was also modified to
express a single terminal alkyne and was allowed to react with
the nanoparticles. Gel electrophoresis verified that several
lipases had covalently attached to each nanoparticle, without
any nonspecific binding, and a lipase assay showed that they
still retained their enzymatic activity. Following a similar
procedure, Fleming et al. (87) were able to conjugate several
different alkynyl derivatives, including ferrocene, aniline, and
PEG, to gold nanoparticles via the click reaction.
Magnetic nanoparticles are of great interest in pharma-
ceutical sciences because of their good biocompatibility,
injectability, and highly specific accumulation in target tissues
under a local magnetic field (88). Several methods have been
investigated to functionalize magnetic nanoparticles (89), but
Lin et al. (90) were one of the first to take advantage of click
chemistry. They successfully attached several different organ-
ic molecules to magnetic particles via the HDC reaction.
These molecules included Tn antigen, flag peptide, biotin,
2,4-dinitrophenol (DNP), and maltose binding protein
(MBP), each of which had been functionalized to contain a
terminal alkyne. The magnetic nanoparticles, on the other
hand, were azide functionalized. Fluorescent tests showed
that each of the bioconjugations was a success and that there
was no nonspecific binding of the 1,2,3-triazole or unreacted
azide. Furthermore, it was observed that the azide linker
length of the magnetic nanoparticles drastically affects how
well MBP, and most likely other proteins, can bind. As linker
length increased, so did binding efficiency, which was
attributed to steric hindrance effects between the bulky
nanoparticle and MBP.
Different from Lin et al., White et al. chose ligands
containing either a phosphonic acid or a carboxylic acid group
at one terminus to bind strongly to the surface of a γ-Fe2O3
nanoparticle, and either an azide or acetylene group at the
other terminus to provide a chemical handle for modification
(91). Both benzyl azide and 5-chloropentyne were then
successfully conjugated through click chemistry. To demon-
strate the versatility of the strategy, an acetylene terminated
polymeric ligand was also attached to the nanoparticles.
Liposomes
Since the pioneering work of Bangham and co-workers
in the late 1950s (92), liposomes have stimulated ongoing
interest in pharmaceutical sciences. Several liposomal for-
mulations have been approved by the US Food and Drug
Administration (FDA) for clinical use, especially for the
treatment of cancers, over the past decade (93). However, this
particular drug carrier still have not attained its full potential;
there are still some aspects that need optimization. Their
surfaces have to be modified to avoid uptake by the
phagocytic cells of the reticular endothelial system (RES),
drug release mechanisms need to be improved so that the
drug is completely and exclusively deposited at the disease
target site, and more efficient strategies for conjugating
targeting moieties (such as peptides and antibodies) to
liposomal surfaces are required. Although great strides have
been taken to resolve each of these issues (94–96), the latter
still remains a problem. Many strategies are highly dependent
upon chemical reactions that are not well-controlled, which
often lead to unwanted products. One of the most popular
methods involves the reaction between functionalized car-
boxylic acid groups and primary amines to form amide bonds
(97). This method does not require prior ligand modification,
thus reduces the risk of losing ligand bioactivity, but there is
often a lack of specificity, resulting in an uncontrolled number
of covalent bonds between the liposome and the targeting
ligands. A much more efficient conjugation method relies on
the reaction of thiol and maleimide functional groups to
produce stable thioether bonds (98). However, in many cases,
native thiol functional groups are either absent or present in
insufficient amounts. Recently, hydrazone linkages have been
studied for conjugation, which involves a mild oxidation of
hydroxyl groups to aldehydes (99). It is obvious that this
oxidation reaction can cause the ligand to loss its activity.
As already mentioned in previous sections, the HDC
reaction is the epitome of linker chemistry and has proven to
be a highly useful conjugation method. Despite this, few
papers can be found relating click chemistry to liposomal
conjugations. Two of these articles will now be discussed.
In a recent report, Hassane et al. (100) developed a novel
strategy for conjugating mannose ligands to the surfaces of
preformed liposomes using the click reaction. The resulting
mannosylated liposomes can serve as vehicles to target
specific cells, such as human dendritic cells (101). In this
strategy, an alkyne terminated lipid anchor was first incorpo-
rated into liposomes. Then an unprotected mannosyl deriva-
tive was functionalized with an azide group and conjugated to
the surface of the liposome in one single step. The group
found that catalytic quantities of the ascorbate/CuSO4 system,
however, were not enough to drive the click reaction to
completion. A stabilizing agent that protects the Cu(I)
oxidation state from degradation pathways had to be added
(for more information on the role of Cu(I)-stabilizing agents
in click chemistry refer to reference 3), which was found to
greatly accelerate the reaction with high yields and reason-
able reaction times (1 h). This conjugation reaction did not
damage the integrity of the bilayers and did not significantly
change the particle size. Residual copper in the conjugated
liposome was not measurable (<0.03 μg/ml), meaning that the
oxidation of unsaturated phospholipids by copper ions is
avoided (102).
Cavalli et al. (103) investigated the facile in-situ surface
modification of liposomes using the click reaction. Firstly, a
mixture of alkyne-terminated 1,2-dioleoyl-sn-glycerol-3-phos-
phoethanolamine (DOPE), 1,2-dioleoyl-sn-glycerol-3-phos-
phocholine (DOPC), and a lissamine rhodamine derivative
of DOPE (DOPE-LR) were sonicated together to prepare
unilamellar liposomes bearing terminal alkyne groups at their
surface. Then an azide-functionalized nitro-benzoxadiazole
(NBD) derivative, N3-Lys(NBD)-NH2, and CuBr were added
to the vesicle solution. Using a method based on fluorescence
resonance energy transfer (FRET), the reaction was followed
in time, showing that the chemical modifications truly did
occur at the surfaces of the liposomes. The reaction was
completed within 4 h, with no dramatic size changes of the
liposomes. These two studies clearly indicate the speed and
versatility of the HDC reaction, allowing both carbohydrates
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and biologicals to be linked to liposome surfaces, regardless
of the other functional groups present.
Bioconjugation
The use of bioconjugation and biopharmaceuticals are
quickly becoming common practice. As of May 1st, 2007, an
estimated 30 biopharmaceuticals are currently in clinical trials
(104). This popularity stems from the fact that bioconjugation
reactions can serve many purposes and satisfy many func-
tional requirements. They are frequently employed to in-
crease aqueous solubility, reduce immunogenicity, increase
circulation time, and improve stability. They can also be used
for radiolabeling and to attach fluorescent tags.
Excluding drug discovery and polymer chemistry, the
most common pharmaceutical applications of click chemistry
are bioconjugation reactions. One reason for this is 1,2,3-
triazoles make ideal linkers. They are extremely water
soluble, making in vivo administration much easier. In fact,
there electronic properties are very similar to amide bonds,
but they are not subject to the same hydrolysis reactions (3).
They are also stable in typical biological conditions, which
tend to be aqueous and mildly reducing in nature (2).
Another advantageous property is they are extremely rigid,
ensuring that the two linked substances are not interacting
with each other (3). If the linker were flexible then the
substances could easily aggregate and/or react with each
other. Furthermore, side reactions at unintended sites of the
substances are a major problem in bioconjugation reactions.
The fact that azides and alkynes are relatively unreactive
towards most functional groups further makes this click
reaction sought after; it ensures that bioconjugation will only
occur at the desired location(s). Finally, as previously
mentioned, this reaction tolerates many different types of
azides and alkynes. Primary, secondary, tertiary, and aromatic
azides will all undergo click chemistry; the steric bulkiness of
the attached group seems to be insignificant. This is important
since many biological molecules, such as globular proteins,
are sterically bulky. Following now is an overview of some
bioconjugation studies that have been performed via click
chemistry.
Radiolabeling
Radiolabeling has become a powerful tool in the
pharmaceutical scientist’s arsenal. By connecting a radionu-
clide to a drug of interest, one can track its in vivo distribution
(105), what specific receptors it attaches to (106), its
metabolic pathway (105), etc. All that is required is a
radionuclide that has desirable decay characteristics and an
instrument that can detect the amount of radiation present.
One particular radionuclide that is commonly used is
technetium-99 m, or 99mTc. This radioisotope has an ideal
half-life of 6 h and emits readily detectable 140 keV gamma
rays (107). It currently has several applications in the medical
field, ranging from identifying angiogenesis via attachment to
monoclonal antibodies to evaluating ventricular function by
conjugation to red blood cells (108,109).
A major obstacle with 99mTc, however, is it can be
difficult to attach to organic molecules. One of the most
common methods used is to take an organometallic precursor,
such as the tricarbonyl molecule [99mTc(OH2)3(CO)3]
+ (110),
and complex it to a tridentate ligand that is already attached
to the molecule of interest (107). This ligand is typically based
on the amino acids cysteine, lysine, and especially histidine
(111). The problems associated with this method, though, are
numerous. The synthesis of such ligands requires multiple
steps, which can be quite challenging, they are not always
easily incorporated into the molecules of interest, and they
can cross react with other functional groups present (107,111).
To avoid these problems, Mindt et al. (111) turned to
click chemistry. Realizing that 1,2,3-triazoles share similar
electronic properties to the imidazoles in histidines and that
they too might be able to complex with organometallic
precursors, the HDC reaction was employed. The facts that
triazoles can be made in one easy step and azides can be
easily incorporated into organic molecules made this strategy
further attractive. By reacting various alkynes and azides,
allowing each to complex with either [99mTc(OH2)3(CO)3]
+ or
[ReBr3(CO)3]
2-, and determining the complexation
efficiencies, EC50 values as high as 2 to 3×10
−7 M were
obtained. These numbers are almost as high as that for NЄ-
methyl histidine (∼1×10−7 M), proving that 1,2,3-triazoles can
chelate organometallic precursors just as well as histidine. To
prove the versatility of the reaction, biomolecules from every
major classification were used (a peptide [bombesin], a nucleic
acid [thymidine], a carbohydrate, and a phospholipid) as click
reaction substrates and subsequently radiolabeled. The
bombesin triazole derivative, in particular, showed in vivo
stability and receptor affinity similar to that of a bombesin
histidine derivative. This further suggests that triazoles could
be a beneficial alternative to histidine when it comes to
complexation with radionuclides.
Tagging E. coli
The proteins expressed on the surfaces of microbial cells
can be used and manipulated for various applications. They
have proved quite useful in a broad range of fields, including
protein engineering, screening for antibody fragments, whole
cell catalysts, adsorbents for bioremediation, etc. (112,113). A
major limitation, however, is there are only 20 naturally-
occurring amino acids. If one could expand the set of amino
acids expressed or specifically replace certain amino acids
with synthetic derivatives then surface proteins could be
further manipulated and the number of potential applications
would be increased exponentially. In this direction, some
research groups have already demonstrated remarkable
success (113).
Capitalizing on the high reliability of the HDC reaction,
Link and Tirrell (113) incorporated an azide-containing
synthetic amino acid into the surface proteins of E. coli. The
amino acid they chose was azidohomoalanine (AHA). It had
been shown previously that AHA can replace methionine
residues in proteins (114) and the outer membrane protein C
(OmpC) of E. coli contains three such residues (115). A
mutant E. coli containing nine methionine residues per
OmpC was also created for comparison. Once AHA had
been incorporated into OmpC for both strains, click reactions
using a biotinylated alkyne reagent were performed. Both
cells were successfully biotinylated, but only the mutant E.
coli would bind with the large molecule avidin, presumably
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due to less steric crowding surrounding the additional
methionine residues.
Tagging CPMV
When wanting to test the bioconjugation abilities of one
or more compounds, Cowpea mosaic virus (CPMV) is
frequently used as the scaffold. It can be made inexpensively
on the gram scale and it is easy to separate from small
unreacted reagents. Furthermore, it contains 60 identical
copies of an asymmetric two-protein unit, each of which
contains one cysteine and one lysine (9,116). These 60
cysteines and lysines can be manipulated and attached to
various functional groups and biomolecules, as evidenced by
countless studies (117–119).
In one study, conducted by Wang et al., fluorescein dye
derivatives were attached to both azide-functionalized and
alkyne-functionalized CPMV using click chemistry (116). Not
only were all of the reactions successful, but also their
product yield was as high as 100%. Two years later, in 2005,
they were able to attach three more hemicyanine dyes to
CPMV using the same reaction (9). Purification can be simply
performed by dialysis or ultrafiltration.
Labeling DNA
Oligonucleotides represent a very important class of
biomolecules. Although they have been “shunned” by the
pharmaceutical community in the past due to lack of
knowledge, they have recently found many applications and
are considered to be the most important tools to many areas
of research (120). They have been used for gene therapy
(121), as antisense agents to treat diseases like leukemia
(122), as molecular probes (123), etc. Adding different
functional groups further increases their versatility, especially
when one considers that functionalization can be introduced
at either the 3′-end, 5′-end, or an internal position. The newly
added functional groups can serve as handles for bioconjuga-
tion with a wide variety of biological molecules. Current
methods for DNA bioconjugation, however, are inefficient.
The procedure must be able to tolerate aqueous conditions,
give high yields, and the resulting linkage must be stable in
biological conditions (124). This is the perfect situation for
click chemistry.
Utilizing the HDC reaction, Seo et al. were able to tag a
fluorophore to the 5′-end of single-stranded DNA (124). The
oligonucleotide was modified, through several reactions, to
display a terminal alkyne at its 5′-end and the fluorophore
contained an azido functional group. A 91% product yield
was obtained, but no catalyst was used in the reaction, leading
to a mixture of 1,4-substituted and 1,5-substituted 1,2,3-
triazole products. If a copper catalyst were used then it is
highly likely that only 1,4-substituted triazoles would be
produced and that the reaction would proceed much faster.
Seela et al. took DNA labeling one step further and
synthesized nucleosides that each contained a single terminal
alkyne on their aromatic nucleobase (125). Modified deoxy-
adenosine (dA), deoxyguanosine (dG), deoxycytidine (dC),
and deoxythymidine (dT) were all included. Using solid
phase synthesis, several oligonucleotides were subsequently
synthesized, which either contained one modified nucleoside,
two, or none at all (to serve as controls). The properties of the
oligonucleotides and their duplexes were not significantly
affected by the modified nucleosides, as evidenced by the
similar melting temperatures when compared to the controls.
Reporter molecules containing azido functional groups were
then conjugated to the modified bases through click chemistry.
Upon conjugation the reporter molecules began to fluoresce,
indicating that the oligonucleotides had been successfully
labeled. If made commercially available, Seela’s modified
nucleosides could make oligonucleotide labeling trivial.
Polysaccharides
Polysaccharides are another major class of macromole-
cules that have received limited attention. Carbohydrates
make up 5% to 10% of plasma membrane mass, in the form
of glycoconjugates, and mediate a variety of events, such as
cell-cell recognition, metastasis, fertilization, and immunolog-
ical response (126,127). Alterations to cell surface oligosac-
charides have been linked to a number of different diseases,
including cancer and tuberculosis (127). Despite these pivotal
biological functions, however, carbohydrates are rarely found
in pharmaceutics. Their synthesis typically involves multiple
reaction steps and many stereoisomers, making it challenging
to even the most skilled chemists. Furthermore, their
moderate affinity towards target receptors and enzymes and
poor pharmacological properties make them seldom used as
targeting moieties/lead compounds (2). Physical modifications
of the carbohydrates can improve both of these issues, but
chemical handles are restricted to alcohol functional groups
and the steric bulkiness of polysaccharides often results in low
product yields.
Due to the easy introduction of azide functional groups
and high reliability of the HDC reaction towards the bulkiest
of reactants, Liebert et al. used click chemistry to modify the
surface of cellulose (128). It was thought that the 1,2,3-
triazoles themselves would interact with biological targets
through hydrogen bonding and dipole interactions, increasing
the overall affinity of cellulose towards its desired target. The
team first introduced azide functional groups into cellulose
through two simple steps: tosylation of the secondary alcohol
groups followed by azidation with sodium azide. The overall
percent yield ranged from 60% to 99%. Three different
terminal alkyne-containing low molecular weight compounds
(methylpropiolate, 2-ethynylaniline, and 3-ethynylthiophene)
were then mixed with three different strands of azide-
celluloses in separate reactions, using a copper(II) salt
catalyst and sodium ascorbate. All reactions were successful
with product yields ranging from 75% to 98%, depending on
the reaction conditions utilized.
In that same year, Hafrén et al. (129) modified cellulose
with click chemistry but took a slightly different approach. In
one single step, terminal alkynes were introduced through the
secondary alcohols of cellulose using 5-hexynoic acid in a neat
reaction. 3-Azidocoumarin and copper catalyst were then
added. Upon reaction, the coumarin-cellulose compound
began to fluoresce a bright blue color, indicating that the
reaction was successful, but no product yield was calculated.
The work of the Liebert and Hafrén research teams clearly
show that polysaccharides can be modified via click chemis-
try. Both azide and terminal alkyne functional groups can be
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easily introduced and the HDC reaction still occurs in high
yields despite steric hindrance.
THE PITFALLS OF CLICK CHEMISTRY
Up until now, this review may have given the impression
that the Cu(I)-catalyzed Huisgen 1,3-dipolar cycloaddition of
terminal alkynes and azides is an “invincible” reaction, always
giving high yields no matter what the situation. However, the
HDC reaction has a number of limitations, each of which will
be discussed. Firstly, like with any cycloaddition, if the diene
(the azide in the case) is too electron deficient then it will not
undergo the reaction. The energy of its ground state
configuration is far too low for it to interact with a dienophile
(the terminal alkyne). Likewise, the dienophile cannot be too
electron rich. These situations are highly unlikely to occur,
though, and require functional groups that are not commonly
seen in biological systems or administered drugs.
A more common problem is alkyne homocoupling. This
occurs when an alkyne reacts with a second alkyne instead of
the azide. As shown in Fig. 7, there are several alkyne
homocoupling side reactions that can occur, three of which
include Glaser (130), Straus (131), and Eglinton couplings
(132,133). Some of these require a CuI catalyst (Glaser and
Straus), while others require CuII (Eglinton) (133). Some
need the presence of oxygen to react (Glaser) while others
can continue in inert atmosphere (Straus) (133). Most of
these reactions, though, can be minimized by using a sterically
bulky base (3). It has been shown that the smaller the base,
the more it stabilizes the reactive intermediates of the
homocoupling reactions (not shown), and the lower the
percent yield of the cycloaddition (3,134,135). The small
bases tetramethylethylenediamine (TMEDA), pyridine, and
triethylamine are frequently the culprits when these side
reactions occur (133,134).
A less common problem is CuI saturation. In order for
the click reaction to take place, the CuI-acetylide complex
intermediate has to have physical contact with the azide (see
section 3.1 for the mechanism). If the complex is closely
surrounded by terminal alkynes, however, then there is a
chance that the alkynes will chelate with the complex, thereby
“saturating” it (3). This effectively prevents any azide
functional groups from reaching the complex and
performing displacement. CuI saturation is rare, though, as
it requires a dienophile that contains multiple terminal
alkynes that can coordinate to a single location. One
notable example came through the work of Zhao et al.
(136). A substrate containing four terminal alkynes in close
proximity was unable to undergo an HDC reaction. However,
when the alkynes were replaced with azide functional groups,
the substrate readily reacted.
The stability of some azides may also be a limitation. It is
known that if the ratio of nitrogen atoms to carbon atoms in
an organic molecule exceeds, or is equal to, one then the
molecule should be considered explosive and very dangerous.
As an example, methyl azide often decomposes explosively
and heavy-metal azides are frequently used as detonators (8).
All that is required is a slight input of external energy, such as
heat or pressure (8). Fortunately, this is generally not a major
issue for pharmaceutical research, which tends to focus on
larger molecules with high carbon contents.
The click reaction also has challenges pertaining specif-
ically to the field of pharmaceutical sciences. One of the most
obvious disadvantages is it requires a copper catalyst.
Although the human body requires copper in order to
function, excessive intake can lead to drastic consequences.
Some associated side effects include hepatitis, neurological
disorders, kidney diseases, and Alzheimer’s disease (137).
The reason for this toxicity stems from the fact that copper
can easily accept and donate single electrons to change
oxidation states, thereby allowing it to catalyze toxic reac-
tions, such as the in vivo reduction of hydrogen peroxide to
form hydroxyl free radicals (138). Therefore, in order for the
click reaction to find in vivo applications, the copper catalyst
must be completely removed. This may not always be an easy
task, but a few research groups have demonstrated some
success. As an example, in the click-PEG delivery system
developed by Liu et al. (67), about 98% of the copper was
effectively removed by incubation with ethylenediaminetetra-
acetic acid (EDTA), followed by dialysis (unpublished data).
However, this approach can only be applied to large
molecular weight structures. Another group, Veinot et al.,
has used oxide-capped metallic iron nanoparticles (139) as Cu
sequester. After performing a click reaction with phenyl azide
and benzyl acetylene, the crude product was incubated with
the nanoparticles twice and filtered twice. Analysis revealed
that the copper concentration had been significantly reduced
from 2,026 ppm to 4.6 ppm.
Another challenge involves biocompatibility of 1,2,3-
triazoles. Despite the fact that they were first identified over a
century ago, not much is known about their biological
pathways. The individual toxicities of some 1,2,3-triazole-
containing compounds have been extensively scrutinized, but
no generalities have been established. As evidenced by a
literature search via SciFinder Scholar on November 12th,
2007 there are no reports reviewing the in vivo metabolism of
1,2,3-triazoles. This is very surprising since many drug
candidates have been synthesized via click chemistry and
1,2,3-triazoles have long been used as bioisosteric replace-
ments of amide functional groups. In fact, the very intent of
click chemistry is for drug discovery.
The final limitation discussed in this paper is, at the
present, many “click-readied” building units and “click
products” are not yet commercially available. This means it
is the responsibility of the pharmaceutical scientist to
synthesize his/her own compounds or to collaborate with
others who can. Even though click reactions are some of the
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Fig. 7. Three types of alkyne homocouplings that can lower the
percent yield of the HDC reaction: Glaser (top), Straus (middle) and
Eglinton (bottom).
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daunting to even the most experienced pharmaceutical scientist,
whose typical background is not in organic synthesis. Fortunate-
ly, click chemistry is still a relatively new idea. As time
progresses and this methodology gains increased acceptance,
more and more products may be made available on the market.
CONCLUSIONS
Despite the fact it debuted less than 10 years ago, click
chemistry is quickly revolutionizing the way scientists view
their research. Although all click reactions are easy to use,
give high reaction yields, do not require long reaction times,
are regiospecific, and are easy to purify, the CuI-catalyzed
Huisgen 1,3-dipolar cycloaddition of azides and terminal
alkynes has emerged as the most popular click reaction by
far. It has found numerous applications across a wide variety
of disciplines, including materials research, polymer
chemistry, and the pharmaceutical sciences. It is particularly
sought after by the pharmaceutical community for its
tolerance of typical biological conditions, tolerance of most
functional groups, and for the high aqueous solubility of 1,2,3-
triazoles. Specifically, the HDC reaction has been used to
synthesize novel polymeric delivery systems, dendrimers, to
cross-link micelles, and to modify the surfaces of various
nanoparticular delivery systems. The rigidity of 1,2,3-triazoles
also makes the reaction ideal for bioconjugations.
Oligonucleotides, proteins, polysaccharides, viruses, and
bacteria such as E. coli have all been successfully
conjugated to various substances using this approach.
The HDC reaction, however, is not perfect. There are a
few important limitations that need to be considered. The
most significant is it requires a copper catalyst. High level of
copper in the body can lead to serious, even deadly, con-
sequences. It is also important to realize that systemic studies
need to be conducted to confirm the biocompatibility of 1,2,3-
triazoles. Other less serious problems include CuI saturation
and alkyne homocoupling.
Though the HDC reaction has several limitations, it is still
one of the most versatile and beneficial chemistry tools for
pharmaceutical applications. We believe that as the industry
recognizes the importance and large potential of this reaction
and provides all of the basic building blocks, it will continue to
grow in popularity and contribute to many major advances in
pharmaceutical sciences and other research fields. Hopefully as
time progresses, other click reactions will also gain momentum
and add additional items to our chemistry “tool box.”
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